BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scurci I, Martins E, Hartley O. CCR5: Established paradigms and new frontiers for a 'celebrity' chemokine receptor. Cytokine 2018;109:81-93. [PMID: 29903576 DOI: 10.1016/j.cyto.2018.02.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Aghili-mehrizi S, Williams E, Yan S, Willman M, Willman J, Lucke-wold B. Secondary Mechanisms of Neurotrauma: A Closer Look at the Evidence. Diseases 2022;10:30. [DOI: 10.3390/diseases10020030] [Reference Citation Analysis]
2 Sathler-Avelar R, Vitelli-Avelar DM, Mattoso-Barbosa AM, Pascoal-Xavier MA, Elói-Santos SM, da Costa-Rocha IA, Teixeira-Carvalho A, Dick EJ Jr, VandeBerg JF, VandeBerg JL, Martins-Filho OA. Phenotypic and Functional Signatures of Peripheral Blood and Spleen Compartments of Cynomolgus Macaques Infected With T. cruzi: Associations With Cardiac Histopathological Characteristics. Front Cell Infect Microbiol 2021;11:701930. [PMID: 34336723 DOI: 10.3389/fcimb.2021.701930] [Reference Citation Analysis]
3 Isaikina P, Tsai CJ, Dietz N, Pamula F, Grahl A, Goldie KN, Guixà-González R, Branco C, Paolini-Bertrand M, Calo N, Cerini F, Schertler GFX, Hartley O, Stahlberg H, Maier T, Deupi X, Grzesiek S. Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist. Sci Adv 2021;7:eabg8685. [PMID: 34134983 DOI: 10.1126/sciadv.abg8685] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
4 Agresti N, Lalezari JP, Amodeo PP, Mody K, Mosher SF, Seethamraju H, Kelly SA, Pourhassan NZ, Sudduth CD, Bovinet C, ElSharkawi AE, Patterson BK, Stephen R, Sacha JB, Wu HL, Gross SA, Dhody K. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. J Transl Autoimmun 2021;4:100083. [PMID: 33521616 DOI: 10.1016/j.jtauto.2021.100083] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
5 Isaikina P, Tsai C, Dietz N, Pamula F, Grahl A, Goldie KN, Guixà-gonzález R, Schertler GF, Hartley O, Stahlberg H, Maier T, Deupi X, Grzesiek S. Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.. [DOI: 10.1101/2020.11.27.401117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Scurci I, Akondi KB, Pinheiro I, Paolini-Bertrand M, Borgeat A, Cerini F, Hartley O. CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties. Biochim Biophys Acta Gen Subj 2021;1865:129753. [PMID: 32991968 DOI: 10.1016/j.bbagen.2020.129753] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
7 Mukaida N, Sasaki SI, Baba T. CCL4 Signaling in the Tumor Microenvironment. Adv Exp Med Biol. 2020;1231:23-32. [PMID: 32060843 DOI: 10.1007/978-3-030-36667-4_3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 18.0] [Reference Citation Analysis]
8 Kulmann-Leal B, Ellwanger JH, Chies JAB. A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer. Hematol Transfus Cell Ther 2020;42:70-6. [PMID: 31822447 DOI: 10.1016/j.htct.2019.10.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Shan J, Li S, Wang C, Liu L, Wang X, Zhu D, Fan Y, Xu J. Expression and biological functions of the CCL5‐CCR5 axis in oral lichen planus. Exp Dermatol 2019;28:816-21. [DOI: 10.1111/exd.13946] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
10 Roffe E, Dos Santos LI, Santos MO, Henriques PM, Teixeira-Carvalho A, Martins-Filho OA, Rocha MOC, Eloi-Santos SM, Correa-Oliveira R, Antonelli LRV. Increased frequencies of circulating CCR5+ memory T cells are correlated to chronic chagasic cardiomyopathy progression. J Leukoc Biol 2019;106:641-52. [PMID: 31087713 DOI: 10.1002/JLB.MA1118-472R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ellwanger JH, Kaminski VDL, Chies JAB. CCR5 gene editing – Revisiting pros and cons of CCR5 absence. Infection, Genetics and Evolution 2019;68:218-20. [DOI: 10.1016/j.meegid.2018.12.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Kaplon H, Reichert JM. Antibodies to watch in 2019. MAbs 2019;11:219-38. [PMID: 30516432 DOI: 10.1080/19420862.2018.1556465] [Cited by in Crossref: 338] [Cited by in F6Publishing: 280] [Article Influence: 84.5] [Reference Citation Analysis]